Skip to main content

Table 1 Clinical and pathological features of reported sebaceous carcinoma of the breast

From: Sebaceous carcinoma of the breast: a case report

Authors (ref. no.)

Year

Age (years)

Sex

Side

ER

PgR

AR

HER2

Oil red O

Sudan Black B

CAM5.2

CK7

Ber-EP4

EMA

MIB-1

Adipophilin

pTNMa

Prognosis

Prescott et al [9]

1992

74

F

R

    

(+)

 

(+)

  

(+)

  

T2NxMx

NA

Mazzella et al. [10]

1995

55

M

L

(+)

(+)

  

(+)

       

T2N0Mx

AWNED, 10 months

Tavassoli [11]

1999

46

F

R

(−)

(+)

        

20%

 

T3N0Mx

NA

Varga et al. [12]

2000

45

F

R

(+)

(+)

 

(−)

      

16%

 

T2NxMx

AWD, 132 months

Hisaoka et al. [13]

2006

71

F

R

(+)

(+)

  

(+)

    

(+)

38%

 

T1cN1-2 Mx

NA

Numoto et al. [14]

2007

49

F

L

(+)

(+)

(+)

(−)

  

(+)

  

(+)

15%

 

T1cNxMx

NA

Murakami et al. [15]

2009

50

F

L

(−)

(−)

(+)

(+)

  

(+)

  

(+)

30%

(+)

T1cN1-2 Mx

AWNED, 24 months

Ramljak et al. [16]

2010

85

F

L

(−)

(−)

 

(−)

      

25%

 

T2NxMx

NA

Å vajdler et al. [17]

2015

65

F

R

(+)

(+)

 

(−)

     

(+)

30%

 

T1cN1aM0

AWNED, 27 months

Å vajdler et al. [17]

2015

61

F

R

(−)

(−)

 

(+)

     

(+)

80%

 

T2N1aM1

DOD, 28 months

Å vajdler et al. [17]

2015

66

F

R

(+)

(+)

 

(+)

      

5%

 

T2N1aM1

AWD, 70 months

Å vajdler et al. [17]

2015

25

F

R

(+)

(+)

 

(−)

     

(+)

  

TxN0Mx

AWNED, 75 months

Yamamoto et al. (current case)

80

F

L

(−)

(−)

(−)

(−)

 

(+)

 

(+)

(+)

(+)

 

(+)

T2N0M0

AWNED, 16 months

  1. Abbreviations: AR androgen receptor, AWD alive with disease, AWNED alive with no evidence of disease, Ber-EP4 EpCAM antibody, CAM5.2 anti-low molecular weight keratin, CK7 cytokeratin 7, DOD died of disease, EMA epithelial membrane antibody, ER estrogen receptor, F female, HER2 human epidermal growth factor receptor type 2, L left, M male, MIB-1 anti-human Ki-67 antigen, NA not available, PgR progesterone receptor, R right
  2. aAccording to International Union Against Cancer TNM Classification of Malignant Tumors (7th Edition)